SEC Form 4 research
| Issuer | 10x Genomics, Inc. |
|---|---|
| Tickers | TXG |
| Reporting owners | 36 |
| Officers and directors | 13 |
| Last public filing | 2026-09-24 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-24 | 2026-09-22 | SULIMAN SHEHNAAZ | S | 1,222 | $82.28 | Not reported |
| 2026-09-24 | 2026-09-22 | SULIMAN SHEHNAAZ | S | 2,270 | $81.67 | Not reported |
| 2026-09-24 | 2026-09-22 | SULIMAN SHEHNAAZ | S | 1,325 | $80.82 | Not reported |
| 2026-09-24 | 2026-09-22 | SULIMAN SHEHNAAZ | S | 614 | $79.51 | Not reported |
| 2026-09-24 | 2026-09-22 | SULIMAN SHEHNAAZ | S | 292 | $78.2 | Not reported |
| 2026-09-24 | 2026-09-22 | Saxonov Serge | S | 2,800 | $82.37 | Not reported |
| 2026-09-24 | 2026-09-22 | Saxonov Serge | S | 9,900 | $81.83 | Not reported |
| 2026-09-24 | 2026-09-22 | Saxonov Serge | S | 9,300 | $80.9 | Not reported |
| 2026-09-24 | 2026-09-22 | Saxonov Serge | S | 2,000 | $79.62 | Not reported |
| 2026-09-24 | 2026-09-22 | Saxonov Serge | S | 1,000 | $78.23 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.